Skip to main content
. Author manuscript; available in PMC: 2013 Oct 28.
Published in final edited form as: Pharm Res. 2009 Jun 25;26(9):10.1007/s11095-009-9923-1. doi: 10.1007/s11095-009-9923-1

Fig. 5.

Fig. 5

(A) Effects of PEGdA content on BSA-FITC release from sIPNs, sIPN of gelatin/PEGdA w/w ratios 10:15 ( graphic file with name nihms429555ig1.jpg), 10:20 ( graphic file with name nihms429555ig2.jpg), 10:30 ( graphic file with name nihms429555ig3.jpg). (B) Effects of gelatin content on BSA-FITC release from sIPNs and PEG-only hydrogels, 15% w/v PEG-only hydrogel ( graphic file with name nihms429555ig1.jpg), sIPN of gelatin/PEGdA w/w ratios 10:15 ( graphic file with name nihms429555ig2.jpg), 15:15 ( graphic file with name nihms429555ig3.jpg), 20:15 ( graphic file with name nihms429555ig4.jpg). Data represented as average ± S.D. (n=3).